Frank Kanniess

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, David C. Dale, James F. Donohue et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 258 citations

Medicine, Pharmacology, Pharmacotherapy +16

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma

Kai-Michael Beeh, Frank Kanniess, Frank Wagner et al. · Journal of Allergy and Clinical Immunology · 2013 · 164 citations

Life Sciences, Immunology, Pharmacology +10

Association of depression and anxiety with health care use and quality of life in asthma patients

Antje Kullowatz, Frank Kanniess, Bernhard Dahme et al. · Respiratory Medicine · 2006 · 158 citations · Full text

Social Sciences, Health Sciences, Mental Health Care +10

In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation

D. Loppow, M.B. Schleiss, Frank Kanniess et al. · Respiratory Medicine · 2001 · 110 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +16

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

Arnaud Bourdin, L. Bjermer, Christopher E. Brightling et al. · European Respiratory Journal · 2019 · 103 citations · Full text

Medicine, Immunology, Internal Medicine +17